Journals / İzmir Atatürk Eğitim Hastanesi Tıp Dergisi / 2008 / Cilt: 46 - Sayı: 1

The comparative prevalence of susceptibility to glycopeptide antiibiotics of methicillin - resistant strains of staphylococci isolated in İzmir Atatürk Training Hospital

İzmir Atatürk Eğitim Hastanesi'nde izole edilen metisilin dirençli stafilokok suşlarının glikopeptid antibiyotiklere duyarlılıklarının karşılaştırmalı prevalansı

Pages
35–38
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In 3 strains (2 MRSA / 1 MRCoNS) of the total 100 Methicillin - resistant Staphylococci, it was seen that susceptibility to teicoplanin was decreased (≤ 14 mm) and susceptibility to vancomycin was high in all.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Methicillin - resistant strains of Staphylococcus aureus (MRSA) and Methicillin-resistant coagulase-negative Staphylococci (MRCoNS) isolated from patients, being infected or colonized, were examined.
📊
Key Findings & Data:In our study, 70 of 100 Staphylocci isolates were MRSA (70 %) and 30 were MRCoNS (30 %). 83 of them had been isolated from clinical materials and 17 had been from outpatients. 58 of total 83 clinical isolates were MRSA (69.9 %) and 25 were MRCoNS (30.1 %). 12 of 17 Methicillin - resistant Staphylococci isolated from outpatients were MRSA (70.6 %) and 5 of them were MRCoNS (29.4 %).
💡
Conclusion & Impact:In 3 strains (2 MRSA / 1 MRCoNS) of the total 100 Methicillin - resistant Staphylococci, it was seen that susceptibility to teicoplanin was decreased (≤ 14 mm) and susceptibility to vancomycin was high in all.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Methicillin - resistant strains of Staphylococcus aureus (MRSA) and Methicillin-resistant coagulase-negative Staphylococci (MRCoNS) isolated from patients, being infected or colonized, were examined. Their susceptibility to glycopeptide antibiotics (vancomycin, teicoplanin) were evaluated by the procedure outlined by the National Committee for Clinical Laboratory Standards using disk agar diffusion method. In our study, 70 of 100 Staphylocci isolates were MRSA (70 %) and 30 were MRCoNS (30 %). 83 of them had been isolated from clinical materials and 17 had been from outpatients. 58 of total 83 clinical isolates were MRSA (69.9 %) and 25 were MRCoNS (30.1 %). 12 of 17 Methicillin - resistant Staphylococci isolated from outpatients were MRSA (70.6 %) and 5 of them were MRCoNS (29.4 %). In 3 strains (2 MRSA / 1 MRCoNS) of the total 100 Methicillin - resistant Staphylococci, it was seen that susceptibility to teicoplanin was decreased (≤ 14 mm) and susceptibility to vancomycin was high in all.

Özet

Stafilococus aureusun metisiline dirençli (MRSA) ve metisilin dirençli koagülaz negatif stafilokok (MRKNS) kökenleriyle enfekte veya kolonize olmuş hastalardan izole edilen suşlar incelendi. Glikopeptid antibiotiklere (vancomycin, teicoplanin) duyarlılıkları NCCLS'nin standartları doğrultusunda disk agar difüzyon yöntemi ile saptandı. Çalışmamızda 100 Stafilokok izolatinin 70'I MRSA (% 70), 30'u MRKN Stafilokok'tu (% 30) MR Stafilokokların 83'ü kliniklerden, 17'si polikliniklerden gelen materyallerden izole edildi. 83 klinik izolatın 58'I (% 69.9) MRSA, 25'I (% 30.1) MRKN Stafilokok, polikliniklerden gelen 17 Metisilin dirençli Stafilokok'un 12'si (% 70.6) MRSA, 5'I (% 29.4) MRKN Stafilokok idi. Toplam 100 adet Metisilin dirençli Stafilokoktan 3'ünde (2 MRSA/1 MRKNS) teicoplanine duyarllığın azaldığı ≤ 14mm, vancomycin duyarllığının ise hepsinde yüksek olduğu gözlendi.

🔖

Cite This Article

KURULTAY, N., TÜRKER, M. (2022). The comparative prevalence of susceptibility to glycopeptide antiibiotics of methicillin - resistant strains of staphylococci isolated in İzmir Atatürk Training Hospital. İzmir Atatürk Eğitim Hastanesi Tıp Dergisi, Cilt: 46 - Sayı: 1, 35–38. https://ajindex.com/articles/557526

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Cercenada M.E, Garcia L, Diaz S. Emergence of Teicoplanin-resistant Coagulase-negative Staphylococci. Journal. Clinic. Microbiol 1996: 1765-68 2. Ünal S. Glikopeptid antibiotikler Vancomycin ve Teicoplanin Flora Dergisi 1997; 2: 4-5 3. Chomavat M, Espinouse D, Coagulase-negative Staphylococci emerging during Teicoplanin therapy and problems in the determination of their sensitivity. Journal Antimicrobial Chemotherapy1991; 27: 475-80. 4. Watanakunakorn C, In vitro selection of resistance of Staphylococcus aureus to Teicoplanin and Vancomycin. Journal Antimicrobial Chemotherapy 1990; 25: 69-72. 5. Wilson A.P.R, Grüneberg R.N. Use of Teicoplanin in community medicine European Journal Clinical Microbiology and Infectious Diseases 1994: 701-10 6. Maniardi JL, Shlaes DM. Decreased Teicoplanin susceptibility of methicillin -resistant strains of Staphylococcus aureus Journal of Infectious Diseases 1995; 171: 1646-50. 7. Williams A.H. Comparative safety of Teicoplanin and other anti-gram positive agents. Royal Society of Medicine Service U.K. 1990: 75-81. 8. Wood MJ. The comparative efficacy and safety of teicoplanin and vancomycin. Journal Antimicrobial Chemotherapy 1996; 37: 209-22. 9. Watanakunakorn C. In vitro Induction of resistance in coagulase-negative staphylococci to vancomycin and teicoplanin Journal Antimicrobial Chemotherapy 1988; 22: 321-24. 10. Rowland M. Clinical Pharmacokinetics of Teicoplanin. Clinical Pharmacokinetics 1990; 18 (3): 184-209.